Abstract
Long-Term Safety and Tolerability of Zavegepant 10 mg Nasal Spray During Concomitant Use of CGRP Monoclonal Antibodies: Results From a 1-Year Open-label Safety Trial (P10-12.009)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have